昨日(ri)晚間，永(yong)安藥業發(fa)布(bu)公(gong)(gong)告稱，2021年2月(yue)1日(ri)，公(gong)(gong)司(si)召開第五屆董事(shi)會第二十次(ci)(ci)(ci)會議審(shen)議通(tong)過《關(guan)于收(shou)購(gou)潛江(jiang)中極氫(qing)(qing)(qing)(qing)能(neng)(neng)源(yuan)發(fa)展(zhan)(zhan)有(you)(you)限公(gong)(gong)司(si)60%股(gu)權的(de)議案》，同意(yi)公(gong)(gong)司(si)以自(zi)有(you)(you)資金收(shou)購(gou)中極氫(qing)(qing)(qing)(qing)能(neng)(neng)源(yuan)60%的(de)股(gu)權，轉(zhuan)讓(rang)(rang)總價款為(wei)人(ren)民(min)幣3600萬(wan)元。此(ci)次(ci)(ci)(ci)交易完成(cheng)后，公(gong)(gong)司(si)將成(cheng)為(wei)中極氫(qing)(qing)(qing)(qing)能(neng)(neng)源(yuan)的(de)新進股(gu)東。同日(ri)，公(gong)(gong)司(si)與(yu)富陽化工、中極氫(qing)(qing)(qing)(qing)能(neng)(neng)源(yuan)正式簽署(shu)《股(gu)權轉(zhuan)讓(rang)(rang)協議》。公(gong)(gong)司(si)表示，收(shou)購(gou)中極氫(qing)(qing)(qing)(qing)能(neng)(neng)源(yuan)是公(gong)(gong)司(si)踐(jian)行轉(zhuan)型發(fa)展(zhan)(zhan)戰略的(de)舉(ju)措，有(you)(you)利(li)于培育新的(de)發(fa)展(zhan)(zhan)方向和利(li)潤增長點，并且中極氫(qing)(qing)(qing)(qing)能(neng)(neng)源(yuan)采用煤制氫(qing)(qing)(qing)(qing)，成(cheng)本相對(dui)較低，經濟可行性更高。此(ci)次(ci)(ci)(ci)投資完成(cheng)后，公(gong)(gong)司(si)將進一步整(zheng)合雙方資源(yuan)，優勢互(hu)補，增強協同效(xiao)應，盡快產生效(xiao)益，但也(ye)可能(neng)(neng)存在(zai)市(shi)場狀況變化、人(ren)員整(zheng)合困難、經營(ying)能(neng)(neng)力(li)不(bu)足等情況，導致不(bu)達預期的(de)風(feng)險。